Partha P. Nath - Publications

Pharmacogenomics of anthracycline-cyclophosphamide-taxane chemotherapy: an influence of CYP polymorphisms and BMI on breast cancer treatment outcomes.

Journal: Pharmacogenomics

Published: December 02, 2025

Total Syntheses of Avapyran and Dysiquinol D through a Stereoconvergent Fusion of Dihydrobenzopyran.

Journal: Organic letters

Published: June 10, 2025

Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study.

Journal: The pharmacogenomics journal

Published: April 03, 2025

Clinicopathological insights and prognostic implications of DEK in association with apoptosis-regulating factors in ovarian cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 12, 2025

Comparative Study of ERK1/2, Bcl2, and Sorcin with Clinicopathological Characteristics of Gastric carcinoma: Tubular Adenocarcinoma Vs Signet Ring Cell Carcinoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: September 04, 2024

Implication of microRNA-regulated PTEN expression in the clinico-pathology & survival outcomes in advanced ovarian cancer.

Journal: The Indian journal of medical research

Published: July 23, 2024

Impact of Low BMI and Nutritional Status on Quality of Life and Disease Outcome in Breast Cancer Patients: Insights From a Tertiary Cancer Center in India.

Journal: Nutrition and cancer

Published: June 05, 2024

Impact of clinicopathological factors and treatment outcomes on gastric cancer survival: A tertiary care hospital-based study in Eastern India.

Journal: Journal of cancer research and therapeutics

Published: April 02, 2024

A novel μ3-CO3 bridged linear polymeric Cu-complex ([Cu3(DMAP)8(μ3-CO3)2]I2) n ·xH2O: synthesis, characterization and catalytic applications in the synthesis of phenoxypyrimidines and arylthiopyrimidines via C-O and C-S cross-coupling reactions.

Journal: RSC advances

Published: January 01, 2024

Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era for the Management of TNBC.

Journal: American journal of clinical oncology

Published: December 25, 2023

A signature of circulating miRNAs predicts the prognosis and therapeutic outcome of taxane/platinum regimen in advanced ovarian carcinoma patients.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 13, 2023

Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer.

Journal: iScience

Published: August 07, 2023